Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease

Scientific Reports(2021)10.1038/s41598-021-02066-9Source: DataRank Database

High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.97)OA: goldTopics (60)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Iazsmin Bauer Ventura ORCID,Cathryn T. Lee ORCID,R. Strykowski ORCID,Nicole Garcia ORCID,Robert D. Guzy ORCID

Live enrichment

PubMed:34819525 PMC:PMC8613201 OpenAlex:https://openalex.org/W3216123495

NHLBI NIH HHS

Grant: K23 HL146942

National Institutes of Health

Grant: 5K23HL146942-05

Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters

Boehringer Ingelheim

Genentech

FibroGen

Galapagos

FWCI

1.97

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-021-02066-9.pdf

publisherhttps://www.nature.com/articles/s41598-021-02066-9.pdf

publisherhttps://www.nature.com/articles/s41598-021-02066-9

journalhttps://doi.org/10.1038/s41598-021-02066-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34819525

Fields of Study

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchRheumatoid Arthritis Research and Therapies03 medical and health sciences0302 clinical medicine

MeSH Terms

LymphadenopathyAdultAgedArthritis, RheumatoidFemaleHumansMaleMediastinal DiseasesMiddle AgedPredictive Value of TestsPrognosisRegistriesRetrospective StudiesRheumatoid FactorRisk FactorsTime FactorsBiomarkersLung Diseases, InterstitialDisease ProgressionRisk Assessment

Keywords

MedicineRheumatoid factorInterstitial lung diseaseInternal medicineRheumatoid arthritisPulmonary function testingGastroenterologySerologyRheumatologyLungImmunologyAntibodyAdultMaleTime FactorsScienceLymphadenopathyRisk AssessmentArticleArthritis, RheumatoidPredictive Value of TestsRisk FactorsMediastinal DiseasesHumansRegistriesAgedRetrospective StudiesQRMiddle AgedPrognosisDisease ProgressionFemaleLung Diseases, InterstitialBiomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort

10.6084/m9.figshare.22625216.v1figshare

Additional file 1 of Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort

10.6084/m9.figshare.22625216figshare